Search results
Insider Sale: CEO Brian Goff Sells Shares of Agios Pharmaceuticals Inc (AGIO) By GuruFocus
Investing.com· 21 hours agoOn June 5, 2024, Brian Goff, Chief Executive Officer of Agios Pharmaceuticals Inc (NASDAQ:AGIO),...
Phio Pharmaceuticals (NASDAQ:PHIO) Stock Price Up 2.5%
ETF DAILY NEWS· 1 day agoPhio Pharmaceuticals Corp. (NASDAQ:PHIO – Get Free Report) rose 2.5% during trading on Thursday . The company traded as high as $0.75 and last traded at ...
Vanda Pharmaceuticals stock: why is it up 20% on Thursday?
Invezz· 2 days agoVanda Pharmaceuticals Inc (NASDAQ: VNDA) is up nearly 20% on Thursday following a report that Cycle ...
Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim
The Motley Fool via AOL· 1 day agoOne stock that is your typical high-risk, high-potential-reward option is Recursion Pharmaceuticals...
Insider Selling: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) EVP Sells $3,043,733.50 in Stock
ETF DAILY NEWS· 6 days agoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) EVP George Eric Davis sold 40,850 shares of the business’s stock in a transaction on Tuesday ...
Ani Pharmaceuticals CFO sells shares worth over $317k By Investing.com
Investing.com· 2 days agoANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has reported a significant transaction involving its Senior...
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Bought by Dimensional Fund Advisors LP
ETF DAILY NEWS· 4 days agoDimensional Fund Advisors LP increased its position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) by 1.3% in the 4th quarter, according to ...
Short Interest in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Rises By 5.4%
ETF DAILY NEWS· 5 days agoInovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Free Report) was the recipient of a large increase in short interest in the month of May. As of May 15th, ...
Insider Sale: EVP & CFO Charles F. Wagner Jr. Sells Shares of Vertex Pharmaceuticals Inc (VRTX) By...
Investing.com· 3 days agoAccording to the SEC Filing, the transaction was executed at a stock price of $460, totaling...
We Think Zentalis Pharmaceuticals (NASDAQ:ZNTL) Can Afford To Drive Business Growth
Simply Wall St. via Yahoo Finance· 4 days agoBut the harsh reality is that very many loss making companies burn through all their cash and go...